| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 10 |
| 1 | ALEMTUZUMAB | 8 |
| 2 | DALFAMPRIDINE | 8 |
| 3 | PREDNISONE | 8 |
| 4 | FULVESTRANT | 6 |
| 5 | ERGOCALCIFEROL | 5 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 5 |
| 7 | ONDANSETRON HYDROCHLORIDE | 5 |
| 8 | PREDNISOLONE | 5 |
| 9 | PREDNISOLONE ORAL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYRAPONE | 3 | 0.0030 |
| 1 | CAPLACIZUMAB | 3 | 0.0017 |
| 2 | INFLIXIMAB-DYYB | 2 | 0.0006 |
| 3 | GILTERITINIB | 2 | 0.0005 |
| 4 | ZOLMITRIPTAN | 3 | 0.0004 |
| 5 | ALEMTUZUMAB | 8 | 0.0004 |
| 6 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 7 | SELENIUM | 1 | 0.0002 |
| 8 | PEGINTERFERON BETA-1A | 3 | 0.0002 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenal Steroid Synthesis Inhibitor [EPC] | 3 | 0.0030 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 8 | 0.0004 |
| 2 | Bismuth [EPC] | 1 | 0.0002 |
| 3 | Estrogen Receptor Antagonist [EPC] | 6 | 0.0001 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 3 | 0.0001 |
| 5 | Potassium Channel Blocker [EPC] | 8 | 0.0001 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Complement Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Aluminum Complex [EPC] | 1 | 0.0000 |